These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6889877)

  • 1. [Identification of chlorzoxazone metabolites in human urine (author's transl)].
    Twele R; Spiteller G
    Arzneimittelforschung; 1982; 32(7):759-63. PubMed ID: 6889877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
    Draper AJ; Madan A; Latham J; Parkinson A
    Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of chlorzoxazone in humans.
    Desiraju RK; Renzi NL; Nayak RK; Ng KT
    J Pharm Sci; 1983 Sep; 72(9):991-4. PubMed ID: 6631711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorometric determination of chlorzoxazone in tablets and biological fluids.
    Stewart JT; Chan CW
    J Pharm Sci; 1979 Jul; 68(7):910-2. PubMed ID: 458615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biotransformation of (+)-methamphetamine in fertile hen's eggs].
    Neugebauer M
    Pharmazie; 1995 Mar; 50(3):201-6. PubMed ID: 7732051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.
    Cannell RJ; Knaggs AR; Dawson MJ; Manchee GR; Eddershaw PJ; Waterhouse I; Sutherland DR; Bowers GD; Sidebottom PJ
    Drug Metab Dispos; 1995 Jul; 23(7):724-9. PubMed ID: 7587961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotransformation of doxylamine: isolation, identification and synthesis of some metabolites (author's transl)].
    Gielsdorf W; Schubert K
    J Clin Chem Clin Biochem; 1981 Jul; 19(7):485-90. PubMed ID: 7328395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
    Gebhardt AC; Lucas D; Ménez JF; Seitz HK
    Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation and identification of some metabolites of bromazine from human urine (author's transl)].
    Goenechea S; Eckhardt G; Fahr W
    Arzneimittelforschung; 1980; 30(9):1580-4. PubMed ID: 6109539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific alterations in the 6-hydroxylation of chlorzoxazone following traumatic brain injury in the rat.
    Poloyac SM; Perez A; Scheff S; Blouin RA
    Drug Metab Dispos; 2001 Mar; 29(3):296-8. PubMed ID: 11181498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of Cl(-) secretion by chlorzoxazone.
    Singh AK; Devor DC; Gerlach AC; Gondor M; Pilewski JM; Bridges RJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):778-87. PubMed ID: 10640318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytochromes P-450 and flavin-containing monooxygenase in the biotransformation of 4-fluoro-N-methylaniline.
    Boersma MG; Cnubben NH; van Berkel WJ; Blom M; Vervoort J; Rietjens IM
    Drug Metab Dispos; 1993; 21(2):218-30. PubMed ID: 8097689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography in pharmaceutical analysis X: Determination of chlorzoxazone and hydroxy metabolite in plasma.
    Honigberg IL; Stewart JT; Coldren JW
    J Pharm Sci; 1979 Feb; 68(2):253-5. PubMed ID: 423105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.